Y-mAbs Therapeutics, Inc. YMAB
8.61 0.00 (+0.00%)
At closeSep 16, 2025, 4:00 PM EDT
8.61 Day range 8.61
8.59 52-week range 8.61
Revenue & Expenses
Revenue by
Latest period ending Dec 31, 2024 · select a line to chart its full history
Income statement
| Fiscal year | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|
| 87.69M | 84.82M | 65.27M | 34.90M | 20.75M | |
| 72.43M | 73.40M | 57.70M | 32.38M | 18.55M | |
| -31.20M | -25.67M | -94.81M | -115.43M | -119.94M | |
| -29.67M | -21.43M | -95.57M | -55.27M | -119.34M | |
| -0.67 | -0.49 | -2.19 | -1.28 | -2.97 |
Balance sheet
| Fiscal year | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|
| 67.23M | 78.64M | 105.76M | 181.56M | 114.63M | |
| 119.90M | 127.87M | 141.46M | 212.78M | 132.05M | |
| 27.90M | 26.88M | 32.23M | 32.68M | 26.21M | |
| 820.00K | 1.42M | 1.77M | 3.63M | 3.98M | |
| 92.00M | 100.98M | 109.22M | 180.11M | 105.84M |
Cash flow
| Fiscal year | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|
| -15.71M | -27.23M | -75.92M | -102.56M | -91.23M | |
| 4.31M | 100.00K | 84.00K | 108.31M | 2.00M | |
| -11.40M | -27.13M | -75.80M | 66.93M | -92.50M |